ZOLPIMIST
Drug
Aytu BioPharma, Inc.
Total Payments
$11,462
Transactions
25
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $11,462 | 25 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,450 | 12 | 91.2% |
| Travel and Lodging | $1,012 | 13 | 8.8% |
Ad
Manufacturing Companies
- Aytu BioPharma, Inc. $11,462
Product Information
- Type Drug
- Total Payments $11,462
- Total Doctors 5
- Transactions 25
About ZOLPIMIST
ZOLPIMIST is a drug associated with $11,462 in payments to 5 healthcare providers, recorded across 25 transactions in the CMS Open Payments database. The primary manufacturer is Aytu BioPharma, Inc..
Payment data is available from 2021 to 2021. In 2021, $11,462 was paid across 25 transactions to 5 doctors.
The most common payment nature for ZOLPIMIST is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,450, 91.2% of total).